Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) carries a US list price of $4,216 per month — one of the highest prices for any single-tablet HIV regimen in the world. It is understandable that patients look south of the border for savings. The reality in Mexico is more nuanced than most comparison sites suggest: prices at licensed private pharmacies do run significantly lower than the US, but availability can be inconsistent, a valid Mexican prescription is required, and the most cost-effective option for many patients — whether Mexican residents or US visitors — may not be a pharmacy visit at all.
This page sets out what Biktarvy actually costs in Mexico in 2026, how Mexico’s public health system distributes it at no charge to enrolled patients, and what US patients need to know about the legal and practical realities of cross-border access.
Sources: Vida Farmacias (2026); Redfarma.com.mx (Feb 2026); Gilead Sciences WAC (Jan 1, 2026). Exchange rate: ~20 MXN/USD (March 2026). Private pharmacy prices vary by location and pharmacy type.
What Biktarvy Costs at Mexican Private Pharmacies
Biktarvy is a brand-name-only medication worldwide — there is no approved generic equivalent in Mexico or anywhere else. What Mexican private pharmacies dispense is the same Gilead-manufactured product sold in the United States, imported under Mexican health regulations. Prices reflect import costs, COFEPRIS regulatory compliance, pharmacy margins, and MXN/USD exchange rate fluctuations.
Based on published pharmacy pricing as of early 2026, a 30-tablet (one-month) supply of Biktarvy at Mexican licensed private pharmacies ranges from approximately MXN $7,500 to MXN $14,257. At March 2026 exchange rates of roughly 20 Mexican pesos to the US dollar, this translates to approximately $375 to $715 USD — a saving of roughly 83–91% compared to the US WAC of $4,216.
- Vida Farmacias (licensed high-specialty chain): MXN $14,257 per 30 tablets — listed in stock online
- Farmacias de Alta Especialidad (certified specialty pharmacies): MXN $7,500–$10,000 range reported by Redfarma (Feb 2026)
- General chain pharmacies in urban areas (e.g. Polanco, Mexico City): MXN $10,000–$13,000 range
- Prices are denominated in Mexican pesos and fluctuate with USD/MXN exchange rate
- No authorized generic of Biktarvy exists — all licensed stock is the Gilead brand product
The variation between pharmacy types is substantial. Certified Farmacias de Alta Especialidad, which specialize in high-cost and specialty medications and are registered with COFEPRIS, tend to offer more competitive pricing on antiretroviral therapy than standard retail chains. The price difference between a specialty pharmacy and a general chain in a wealthy urban area can exceed MXN $5,000 per month for the same product.
Stock availability: Biktarvy availability at Mexican private pharmacies is not guaranteed. Our prior survey of pharmacies in border areas found significant stock-out rates. Vida Farmacias, operating in Mexico City, Guadalajara, and Monterrey, lists the medication online with confirmed availability. If you are traveling to Mexico to obtain Biktarvy, contact the pharmacy before your visit to confirm current stock.
Biktarvy Price Comparison: Mexico vs USA
| Source / Scenario | Monthly Cost (USD) | Notes |
|---|---|---|
| Mexico — Specialty pharmacy | ~$375–$500 | Farmacia de Alta Especialidad, COFEPRIS-registered; MXN $7,500–$10,000 |
| Mexico — Chain pharmacy | ~$500–$715 | General retail chain; MXN $10,000–$14,257; less consistent stock |
| Mexico — Public system (IMSS/ISSSTE/CAPASITS) | $0 | Enrolled Mexican patients; requires registration; not available to US visitors |
| USA — List price (WAC) | $4,216 | Gilead wholesale acquisition cost, Jan 1, 2026; few patients pay this |
| USA — Commercial insurance + Gilead co-pay coupon | $0–$5 | Commercially insured patients via Gilead Advancing Access; most common US scenario |
| USA — Medicare Part D (2025 cap) | ≤$167/mo | $2,000 annual OOP cap; 80% of Medicare patients pay ≤$15/month |
| USA — Medicaid | $0 | Most Medicaid beneficiaries pay $0 for Biktarvy |
| USA — Uninsured, no assistance | ~$3,874–$4,216 | GoodRx cash price range at US retail pharmacies (2026) |
The critical comparison for US patients: If you have commercial insurance in the USA, the Gilead Advancing Access co-pay coupon typically reduces Biktarvy to $0–$5 per month — far less than any private pharmacy price in Mexico. The Mexico option is most relevant for uninsured US patients who do not qualify for Medicaid and cannot access Gilead’s patient assistance program, or for patients who reside in Mexico.
Free Biktarvy Through Mexico’s Public Health System
For patients enrolled in Mexico’s national health institutions, Biktarvy is provided at no cost as part of the country’s universal HIV treatment programme. Mexico’s national HIV response is coordinated by CENSIDA (Centro Nacional para la Prevención y el Control del VIH/SIDA) under the Secretaría de Salud.
Mexico was the first country in Latin America to undertake a large-scale national rollout of Biktarvy, following a landmark 2019 agreement between CENSIDA and Gilead Sciences in which Gilead agreed to supply Biktarvy at a substantially discounted government purchase price. The agreement was structured to ensure a continuous supply — replacing older multi-pill regimens and simplifying treatment for both treatment-naïve patients and those switching from previous antiretrovirals.
Which Institutions Provide Free Biktarvy?
| Institution | Coverage Basis | HIV Treatment Access |
|---|---|---|
| IMSS (Mexican Social Security Institute) | Formal employment-based | Free ART including Biktarvy for enrolled workers and dependents |
| ISSSTE (State Workers’ Social Security) | Federal government employees | Free ART including Biktarvy for enrolled state workers |
| CAPASITS clinics (CENSIDA/Secretaría de Salud) | Uninsured Mexican residents | Free HIV treatment at outpatient centres nationwide; Clínica Condesa in Mexico City |
| INSABI clinics | Migrants, refugees, uninsured persons | Free HIV services under NOM-010-SSA2-2023 regardless of immigration status |
Legal right regardless of immigration status: Under Mexico’s NOM-010-SSA2-2023 standard for HIV prevention and control, all persons in Mexico — regardless of nationality or immigration status — have the legal right to access HIV health services. US citizens residing or staying in Mexico are not categorically excluded from public HIV care, though enrollment pathways vary by institution and individual circumstances. Clínica Condesa in Mexico City has historically provided treatment to migrants and non-residents.
Is Biktarvy Available in Mexico?
Biktarvy has been available in Mexico since late 2019, but the picture differs sharply between the public and private sectors. Within the public system, supply has been significantly reinforced following the 2019 CENSIDA–Gilead agreement, which established Mexico as having the largest national stock of Biktarvy in the world at the time of the deal. Within the private pharmacy sector, availability is less predictable.
High-specialty pharmacy chains like Vida Farmacias, which operate in major metropolitan areas (Mexico City, Guadalajara, Monterrey), maintain consistent stock and list Biktarvy online for purchase with delivery. Border-area pharmacies — including those in Tijuana, Ciudad Juárez, and Nogales — have historically had irregular stock, with some pharmacies unable to obtain the medication at all during periods of supply constraint. Patients should not assume that a Tijuana-area pharmacy will have Biktarvy in stock without prior confirmation.
Counterfeit risk: Gilead Sciences has publicly warned that counterfeit versions of Biktarvy circulate in unregulated markets. Only purchase from pharmacies licensed by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), Mexico’s health regulatory authority. A licensed pharmacy will require a valid prescription and will provide a receipt identifying the product’s lot number and expiry date.
What US Patients Need to Know
Prescription Requirements in Mexico
Biktarvy is a prescription-only medication in Mexico. Licensed COFEPRIS-registered pharmacies are legally required to dispense it only with a valid prescription issued by a licensed Mexican physician. A US prescription is not automatically valid in Mexico. Patients traveling from the United States to purchase Biktarvy will need to obtain a Mexican prescription — either through a consultation with a Mexican physician, a telemedicine service operating within Mexico, or a clinic near the border.
Bringing Biktarvy Across the US Border
Under FDA personal import policy, US residents may import a personal supply of up to 90 days’ worth of a prescription medication for personal use. The medication must be declared to US Customs and Border Protection (CBP) at the border crossing. CBP officers exercise discretion, and there is no absolute guarantee that the medication will be allowed entry. To minimize complications, carry a copy of your US prescription, ensure the medication is in the original labeled packaging, and declare it proactively at customs.
- Quantity limit: FDA personal importation policy allows up to a 90-day personal supply. Do not attempt to import more than this quantity.
- Declaration required: Always declare the medication to CBP when crossing the border. Failure to declare can result in seizure and penalties.
- Original packaging: Keep the medication in original Gilead-labeled packaging to confirm product identity and authenticity.
- US prescription copy: Carry a copy of your US prescription or a letter from your physician confirming the medication is for your personal HIV treatment.
- No resale: Personal importation for resale or distribution is illegal. This policy applies strictly to personal use.
Is the Mexico Option Right for You?
For most US patients with commercial insurance, the Gilead Advancing Access co-pay coupon reduces Biktarvy to $0–$5 per month — making the Mexico option unnecessary from a cost perspective. The Mexico route is most relevant for patients who are uninsured, do not qualify for Medicaid, and cannot access Gilead’s Patient Assistance Program due to income thresholds. Before traveling to Mexico for medication, exhaust all US-based assistance options first.
US-based assistance options to try first: Gilead Advancing Access offers a co-pay coupon (commercially insured, $0–$5/month) and a Patient Assistance Program for uninsured patients who meet income criteria. Call 1-800-226-2056 or visit gileadadvancingaccess.com. Medicaid covers Biktarvy for eligible patients at $0. Medicare Part D caps annual out-of-pocket spending at $2,000 (2025). See our full guide at Biktarvy cost without insurance →
Frequently Asked Questions
At Mexican private pharmacies, Biktarvy (30 tablets, one month’s supply) costs approximately MXN $7,500 to MXN $14,257, which is roughly $375 to $715 USD at current exchange rates (March 2026). Specialty pharmacies registered with COFEPRIS tend to offer lower prices than general chain pharmacies. Mexico’s public health institutions — including IMSS, ISSSTE, and CAPASITS clinics under CENSIDA — provide Biktarvy at no cost to enrolled beneficiaries.
Biktarvy has been approved for use in Mexico since 2019 and is available, but stock can be inconsistent — particularly at smaller or border-area pharmacies. Vida Farmacias, a licensed high-specialty pharmacy chain operating in Mexico City, Guadalajara, and Monterrey, lists Biktarvy in stock online. Availability is generally more reliable at certified Farmacias de Alta Especialidad (high-specialty pharmacies) registered with COFEPRIS than at standard retail chains.
US residents may import a personal supply of up to a 90-day quantity of prescription medication for personal use under FDA personal import policy. The medication must be for a serious condition, must not pose an unreasonable risk, and must be declared at the border with a valid prescription. Customs and Border Protection (CBP) officers have discretion, and there is no absolute guarantee of entry. Commercially purchasing large quantities or importing for resale is prohibited.
Yes. Mexico’s national HIV programme, coordinated by CENSIDA (Centro Nacional para la Prevención y el Control del VIH/SIDA), provides antiretroviral therapy including Biktarvy at no cost to enrolled patients through public institutions including IMSS, ISSSTE, and CAPASITS clinics. In 2019, Gilead Sciences agreed to a large-volume discounted purchase with the Mexican government, enabling a national Biktarvy rollout — the first such rollout in Latin America. Under Mexican law (NOM-010-SSA2-2023), all persons in Mexico, regardless of immigration status, have the legal right to HIV health services.
Biktarvy purchased from licensed pharmacies registered with COFEPRIS (Mexico’s health regulatory authority) is the authentic Gilead product and is safe. Gilead Sciences has warned that counterfeit versions of Biktarvy circulate in unregulated markets. Always purchase from a COFEPRIS-registered pharmacy, verify the packaging matches Gilead’s official labeling, and ensure the pharmacy requires a valid prescription.
Yes. Biktarvy is a prescription-only medication in Mexico. Licensed pharmacies registered with COFEPRIS are required to dispense it only with a valid Mexican prescription. A prescription issued by a licensed Mexican physician is required. US prescriptions are not automatically valid in Mexico, though some border clinics and telemedicine services can facilitate a Mexican prescription for patients traveling from the United States.
How we reviewed this article:
Ana Goios researched and wrote this article using peer-reviewed clinical literature, official regulatory sources (COFEPRIS, CENSIDA, FDA), published pharmacy pricing data, and Gilead Sciences pricing documentation. Dr. Brendan Payne reviewed the medical and clinical content for accuracy and completeness. Pricing data reflects sources available as of March 2026 and is subject to exchange rate and pharmacy-level variation.
Read our editorial policy →References
- Gilead Sciences. gileadpriceinfo.com — BIKTARVY Cost Information. Wholesale Acquisition Cost as of January 1, 2026.
- Vida Farmacias. vidafarmacias.com — Biktarvy 50 mg/200 mg/25 mg, 30 Tablets. Accessed March 2026.
- Redfarma. redfarma.com.mx — Biktarvy Precio México 2026: Guía de Ahorro y Farmacias. February 2026.
- MedicalMex. medicalmex.com — Biktarvy: Canada and Mexico Savings vs US Retail. October 2025.
- GoodRx. goodrx.com — How Much Is Biktarvy Without Insurance? Updated 2025.
- Foreign Policy. foreignpolicy.com — Mexico Is Setting a Global Example on HIV Treatment. November 2019.
- Positive Destinations (UNAIDS/NAT). positivedestinations.info — Mexico: HIV Travel and Legal Information. Accessed March 2026.
- AETC National Coordinating Resource Center. aidsetc.org — Brand and Generic Names of ARVs in the USA and Mexico. Accessed March 2026.
- Navarrete-Opazo AA et al. Comparative effectiveness of switching to bictegravir from dolutegravir-, efavirenz-, or raltegravir-based ART in Mexico. Open Forum Infectious Diseases. 2024.
- US Food and Drug Administration. fda.gov — Buying Medicine Outside the United States. Accessed March 2026.